# Aardvark Therapeutics, Inc. Common Stock (AARD)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/AARD/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -35.98M | $ -36.47M | $ 677.0K | $ 74.80M |
| 2025 | $ 0 | $ -58.97M | $ -55.56M | $ 441.0K | $ 106.63M |
| 2024 | $ 0 | $ -21.64M | $ -19.13M | $ 779.0K | $ -54.64M |
| 2023 | $ 0 | $ -4.49M | $ -2.96M | $ 162.0K | $ -34.80M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.01 |
| Liabilities / Eq | 0.09 |
| Current Ratio | 12.63 |

## Other views

- [Metrics](https://sponda.capital/en/AARD.md)
- [Charts](https://sponda.capital/en/AARD/charts.md)
- [Compare](https://sponda.capital/en/AARD/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.